Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10.

FDA recall notice · announced April 11, 2018 · Mayne Pharma

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10.

Reason for recall

Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.

Notes

Distribution: Nationwide in the USA
Lot/code information: Lot: MBEB, Exp. 01/31/2019
Quantity: 3312 cans
Status: Terminated
Products in this recall event:
- Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10. (D-0616-2018)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.